New Zealand’s Covid-free status is attracting more US biotech and pharmaceutical companies than ever to run clinical trials here.
Industry players say leveling the field with Australia in terms of government incentives would enable the sector to fully exploit the boom, bringing wider economic
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
